Literature DB >> 10367695

Daytime somnolence in myotonic dystrophy.

M F Phillips1, H M Steer, J R Soldan, C M Wiles, P S Harper.   

Abstract

Somnolence in myotonic dystrophy (DM) has not been measured using a reliable daytime somnolence scale. The aim of this study was to compare somnolence in DM patients with healthy controls and Charcot-Marie-Tooth disease (CMT) patients using such a scale and to compare this with potential contributory factors. We investigated 35 subjects with adult-onset DM, 16 healthy controls and 13 CMT controls. The Epworth Sleepiness Scale (ESS) was the principal measurement of daytime somnolence. Nocturnal sleep was assessed using a sleep diary. Other assessments measured daytime respiratory function, cognitive function, motor impairment, disability, swallowing capacity and depression. DM and CMT patients had greater daytime sleepiness than unaffected controls. In the DM group significant correlations were found between somnolence and measures of disability, sleep quality and some measures of depression. It was concluded that there is an abnormal level of daytime somnolence in DM, which is partially associated with disability.

Entities:  

Mesh:

Year:  1999        PMID: 10367695     DOI: 10.1007/s004150050346

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  Diagnosing And Treating Co-Morbid Sleep Apnea In Neurological Disorders.

Authors:  Erik K St Louis
Journal:  Pract Neurol (Fort Wash Pa)       Date:  2010-07-01

2.  Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study.

Authors:  Huan Yu; Luc Laberge; Isabelle Jaussent; Sophie Bayard; Sabine Scholtz; Morales Raoul; Michel Pages; Yves Dauvilliers
Journal:  Sleep       Date:  2011-02-01       Impact factor: 5.849

3.  Towards an integrative approach to the management of myotonic dystrophy type 1.

Authors:  Cynthia Gagnon; Luc Noreau; Richard T Moxley; Luc Laberge; Stéphane Jean; Louis Richer; Michel Perron; Suzanne Veillette; Jean Mathieu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-20       Impact factor: 10.154

Review 4.  Daytime sleepiness and myotonic dystrophy.

Authors:  Luc Laberge; Cynthia Gagnon; Yves Dauvilliers
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

5.  Methylphenidate Attenuates the Cognitive and Mood Alterations Observed in Mbnl2 Knockout Mice and Reduces Microglia Overexpression.

Authors:  Carla Ramon-Duaso; Thomas Gener; Marta Consegal; Cristina Fernández-Avilés; Juan José Gallego; Laura Castarlenas; Maurice S Swanson; Rafael de la Torre; Rafael Maldonado; M Victoria Puig; Patricia Robledo
Journal:  Cereb Cortex       Date:  2019-07-05       Impact factor: 5.357

Review 6.  Respiratory involvement in inherited primary muscle conditions.

Authors:  N Shahrizaila; W J M Kinnear; A J Wills
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10       Impact factor: 10.154

Review 7.  Neuromuscular disorders and sleep.

Authors:  Ibrahim Oztura; Christian Guilleminault
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

8.  Diagnosing and Treating Co-morbid Sleep Apnea in Neurological Disorders, Part II.

Authors:  Erik K St Louis
Journal:  Pract Neurol (Fort Wash Pa)       Date:  2010-09

9.  Sleep disturbances in myotonic dystrophy type 2.

Authors:  Paul Shepard; Erek M Lam; Erik K St Louis; Jacob Dominik
Journal:  Eur Neurol       Date:  2012-10-25       Impact factor: 1.710

10.  Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness.

Authors:  Esen Kiyan; Gulfer Okumus; Caglar Cuhadaroglu; Feza Deymeer
Journal:  Sleep Breath       Date:  2009-05-30       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.